Belgium’s Superior Health Council has advised against the use of AstraZeneca’s vaccine for the most vulnerable people and it will therefore be restricted only to people under the age of 55, RTBF reported.
Federal Health Minister Frank Vandenbroucke said, “We lack data […] we have to work on the basis of what is certain.”
When the European Medicines Agency approved on 29 January AstraZeneca’s vaccine, it acknowledged that the study data for people over 55 were scarce.
“There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group. However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines”, EMA said.
At the EU level, France, Germany, Sweden, Poland, and Italy do not recommend the AstraZeneca vaccine for people over 65.